Control of the adaptive immune response by tumor vasculature by Laetitia eMauge, Laetitia eMauge, Magali eTerme, Eric eTartour, Eric eTartour, Dominique eHelley, Dominique eHelley

Get full text

Tissue-resident memory T cells play a key role in the efficacy of cancer vaccines by C. Granier, C. Blanc, S. Karaki, T. Tran, H. Roussel, E. Tartour

Get full text

Immunotherapy in older patients with cancer by C. Granier, A. Gey, S. Roncelin, L. Weiss, E. Paillaud, E. Tartour

Get full text

Control of the immune response by proangiogenic factors by Thibault eVORON, Elie eMARCHETEAU, Simon ePERNOT, Simon ePERNOT, Orianne eCOLUSSI, Orianne eCOLUSSI, Eric eTARTOUR, Eric eTARTOUR, Julien eTAIEB, Julien eTAIEB, Magali eTERME

Get full text

The ultimate goal of curative anti-cancer therapies : inducing an adaptive anti-tumor immune response by Wolf Hervé eFridman, Wolf Hervé eFridman, Wolf Hervé eFridman, Jean-Luc eTEILLAUD, Jean-Luc eTEILLAUD, Catherine eSautès-Fridman, Catherine eSautès-Fridman, Franck ePagès, Franck ePagès, Jérôme eGalon, Jérôme eGalon, Jérôme eGalon, Jessica eZucman-Rossi, Jessica eZucman-Rossi, Jessica eZucman-Rossi, Eric eTartour, Eric eTartour, Eric eTartour, Laurence eZITVOGEL, Laurence eZITVOGEL, Laurence eZITVOGEL, Laurence eZITVOGEL, Guido eKroemer, Guido eKroemer, Guido eKroemer, Guido eKroemer, Guido eKroemer, Guido eKroemer

Get full text

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

Get full text